After almost 50 years without any substantial progress, antithrombotic treatment of patients with venous thromboembolism has
finally evolved. Factor Xa or thrombin inhibitors will probably allow antithrombotic treatment that is effective, safe, and
simple enough for all physicians to use in most outpatients.